| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |